Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.28 USD | +0.49% | +13.98% | +66.69% |
Apr. 01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
Apr. 01 | Solid Biosciences Gets FDA Rare-Pediatric Designation for SGT-003 in Duchenne | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+66.69% | 387M | |
-1.15% | 103B | |
+8.69% | 101B | |
+4.40% | 23.07B | |
-12.28% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.45% | 16.94B | |
+7.17% | 14.07B | |
+38.63% | 12.35B |
- Stock Market
- Equities
- SLDB Stock
- News Solid Biosciences Inc.
- Transcript : Solid Biosciences Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 09